Institutional Ownership Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the 161 institutions that hold shares in the stock, with a total of 55.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.08 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bvf Inc
San Francisco, CA |
May 15, 2025 Q1 2025 |
19,751,284
shares
|
$743 Million
33.91% of portfolio
|
Q4 2024
Reduced 9.19%
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
8,494,151
shares
|
$320 Million
35.2% of portfolio
|
Q4 2023
Added 4.32%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,973,830
shares
|
$112 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.06%
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,770,100
shares
|
$104 Million
1.75% of portfolio
|
Q3 2024
Added 0.0%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
1,478,635
shares
|
$55.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 32.39%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
1,434,770
shares
|
$54 Million
0.29% of portfolio
|
Q1 2025
Added 9.39%
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
1,292,608
shares
|
$48.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 22.81%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 08, 2025 Q1 2025 |
1,269,351
shares
|
$47.8 Million
0.11% of portfolio
|
Q1 2025
Reduced 0.84%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
1,100,000
shares
|
$41.4 Million
0.29% of portfolio
|
Q4 2024
Added 120.0%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
966,090
shares
|
$36.3 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.53%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
894,005
shares
|
$33.6 Million
0.05% of portfolio
|
Q2 2023
New holding
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
673,343
shares
|
$25.3 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
May 15, 2025 Q1 2025 |
662,983
shares
|
$24.9 Million
0.49% of portfolio
|
Q1 2025
Added 2.06%
|
|
Fred Alger Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
642,881
shares
|
$24.2 Million
0.15% of portfolio
|
Q1 2025
Reduced 4.58%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
640,917
shares
|
$24.1 Million
0.03% of portfolio
|
Q1 2025
Reduced 48.53%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
627,423
shares
|
$23.6 Million
1.26% of portfolio
|
Q1 2025
Reduced 64.6%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
595,581
shares
|
$22.4 Million
0.01% of portfolio
|
Q4 2024
Added 2.55%
|
|
Camber Capital Management LP
Boston, MA |
May 15, 2025 Q1 2025 |
441,000
shares
|
$16.6 Million
0.65% of portfolio
|
Q3 2024
Added 24.23%
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2025 Q1 2025 |
435,785
shares
|
$16.4 Million
1.8% of portfolio
|
Q1 2025
Reduced 2.71%
|
|
Voya Investment Management LLC
Atlanta, GA |
May 15, 2025 Q1 2025 |
392,924
shares
|
$14.8 Million
0.02% of portfolio
|
Q1 2025
Reduced 12.46%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
392,024
shares
|
$14.7 Million
0.0% of portfolio
|
Q2 2024
Reduced 3.98%
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
350,000
shares
|
$13.2 Million
2.66% of portfolio
|
Q1 2025
New holding
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
344,320
shares
|
$13 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
Saturn V Capital Management LLC
Austin, TX |
May 15, 2025 Q1 2025 |
343,849
shares
|
$12.9 Million
6.78% of portfolio
|
Q1 2025
Reduced 0.65%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
322,114
shares
|
$12.1 Million
0.01% of portfolio
|
Q1 2025
Reduced 7.07%
|